BIOMAT Database Logo BIOMAT Database Logo

[Wild type p53 tumor suppressor gene and apoptosis in thyroid tumors: preliminary report]. 1995

S Kikuchi, and H Hiraide, and S Tamakuma, and M Yamamoto
National Defense Medical College 1st Surgery, Tokorozawa, Japan.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013964 Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. Cancer of Thyroid,Thyroid Cancer,Cancer of the Thyroid,Neoplasms, Thyroid,Thyroid Adenoma,Thyroid Carcinoma,Adenoma, Thyroid,Adenomas, Thyroid,Cancer, Thyroid,Cancers, Thyroid,Carcinoma, Thyroid,Carcinomas, Thyroid,Neoplasm, Thyroid,Thyroid Adenomas,Thyroid Cancers,Thyroid Carcinomas,Thyroid Neoplasm
D016158 Genes, p53 Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53. Genes, TP53,TP53 Genes,p53 Genes,Gene, TP53,Gene, p53,TP53 Gene,p53 Gene
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

S Kikuchi, and H Hiraide, and S Tamakuma, and M Yamamoto
Hsp90 chaperones wild-type p53 tumor suppressor protein.
November 2004, The Journal of biological chemistry,
S Kikuchi, and H Hiraide, and S Tamakuma, and M Yamamoto
CHIP chaperones wild type p53 tumor suppressor protein.
September 2007, The Journal of biological chemistry,
S Kikuchi, and H Hiraide, and S Tamakuma, and M Yamamoto
Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.
January 1991, Molecular and cellular biology,
S Kikuchi, and H Hiraide, and S Tamakuma, and M Yamamoto
Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53.
December 1999, Oncogene,
S Kikuchi, and H Hiraide, and S Tamakuma, and M Yamamoto
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments].
December 1998, Annals of surgical oncology,
S Kikuchi, and H Hiraide, and S Tamakuma, and M Yamamoto
Mutant and Wild-Type Tumor Suppressor p53 Induces p300 Autoacetylation.
June 2018, iScience,
S Kikuchi, and H Hiraide, and S Tamakuma, and M Yamamoto
The p53 tumor suppressor gene and pediatric brain tumors.
December 1994, Current opinion in pediatrics,
S Kikuchi, and H Hiraide, and S Tamakuma, and M Yamamoto
Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
August 2001, Cancer research,
S Kikuchi, and H Hiraide, and S Tamakuma, and M Yamamoto
Altered expression of wild-type p53 tumor suppressor gene during murine epithelial cell transformation.
February 1992, Cancer research,
S Kikuchi, and H Hiraide, and S Tamakuma, and M Yamamoto
Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins.
August 2000, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!